Adequan®
About Adequan
Polysulfated glycosaminoglycan (PSGAG), sold under the brand name Adequan, is an injectable drug for dogs (Adequan® Canine) and horses (Adequan® I.M) that is used to alleviate the lameness, pain, and lowered range of motion caused by arthritis.
Adequan® Canine
Adequan® Canine (polysulfated glycosaminoglycan) is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss in the dog’s joints, and may help to:
- Restore joint lubrication
- Relieve inflammation
- Renew the building blocks of healthy cartilage
Adequan® I.M for Horses
As the only FDA-approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses, Adequan® i.m. actually treats degenerative joint disease (DJD), not just its clinical signs. It contributes to:
- Reduce inflammation
- Restore synovial joint lubrication
- Repair joint cartilage
- Reverse the disease process
Showing all 3 results